Document is current
Any future updates will be listed below
-
Authors
Accogli, Théo
Hibos, Christophe https://orcid.org/0000-0003-0191-363X
Milian, Lylou
Geindreau, Mannon
Richard, Corentin
Humblin, Etienne
Mary, Romain
Chevrier, Sandy
Jacquin, Elise https://orcid.org/0000-0003-0368-4113
Bernard, Antoine
Chalmin, Fanny
Paul, Catherine
Ryffel, Berhard https://orcid.org/0000-0003-2897-8230
Apetoh, Lionel https://orcid.org/0000-0002-2774-438X
Boidot, Romain
Bruchard, Mélanie
Ghiringhelli, François https://orcid.org/0000-0002-5465-8305
Vegran, Frédérique https://orcid.org/0000-0002-4377-1441
- License Information
-
More Information
Article History
Received: 19 June 2024
Accepted: 14 March 2025
First Online: 7 April 2025
Competing interests
: FG received speaker honoraria from Lilly, Sanofi, BMS, Astra Zeneca and Amgen; received funding for clinical trials from Astra Zeneca; received travel grants from Roche France, Amgen and Servier; and is an advisory board member for Merck Serano, Amgen, Roche France and Sanofi. No other authors have any potential conflicts of interest to disclose.
